Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Mechanisms of impaired hypothalamic-pituitary-adrenal (HPA) function in diabetes: reduced counterregulatory responsiveness to hypoglycaemia.

Inouye K, Chan O, Riddell MC, Akirav E, Matthews SG, Vranic M.

Diabetes Nutr Metab. 2002 Oct;15(5):348-55; discussion 355-6, 362. Review.

PMID:
12625483
2.
3.

Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia.

Chan O, Inouye K, Akirav EM, Park E, Riddell MC, Matthews SG, Vranic M.

Am J Physiol Regul Integr Comp Physiol. 2005 Jul;289(1):R235-46. Epub 2005 Mar 17.

4.

Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis.

Chan O, Inouye K, Riddell MC, Vranic M, Matthews SG.

Minerva Endocrinol. 2003 Jun;28(2):87-102. Review.

PMID:
12717340
5.

The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.

Fiad TM, Kirby JM, Cunningham SK, McKenna TJ.

Clin Endocrinol (Oxf). 1994 May;40(5):603-9.

PMID:
8013141
7.

Identification of stimulatory and inhibitory inputs to the hypothalamic-pituitary-adrenal axis during hypoglycaemia or transport in ewes.

Smith RF, French NP, Saphier PW, Lowry PJ, Veldhuis JD, Dobson H.

J Neuroendocrinol. 2003 Jun;15(6):572-85.

PMID:
12716408
8.

Comparison of pituitary-adrenocortical response to hypoglycaemia and surgery.

Blichert-Toft M, Christiansen C, Engquist A, Kehlet H, Lindholm J, Hummer L, Dinesen B.

Acta Anaesthesiol Scand. 1979 Feb;23(1):103-6.

PMID:
218420
9.

Effects of diabetes and recurrent hypoglycemia on the regulation of the sympathoadrenal system and hypothalamo-pituitary-adrenal axis.

Inouye KE, Chan O, Yue JT, Matthews SG, Vranic M.

Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E422-9. Epub 2004 Oct 19.

10.

Lack of menstrual cycle effects on hypothalamic-pituitary-adrenal axis response to insulin-induced hypoglycaemia.

Long TD, Ellingrod VL, Kathol RG, Christensen LE, Resch DS, Perry PJ.

Clin Endocrinol (Oxf). 2000 Jun;52(6):781-7.

PMID:
10848884
11.

Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.

Broglio F, Prodam F, Gottero C, Destefanis S, Me E, Riganti F, Giordano R, Picu A, Balbo M, Van der Lely AJ, Ghigo E, Arvat E.

Clin Endocrinol (Oxf). 2004 Jun;60(6):699-704.

PMID:
15163333
12.

Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induced diabetes: effects of insulin treatment.

Chan O, Chan S, Inouye K, Vranic M, Matthews SG.

Endocrinology. 2001 Nov;142(11):4872-9.

PMID:
11606455
13.
14.

Insulin hypoglycaemia test guided by a glucose controlled insulin infusion system.

Müller-Esch G, Ball P, Heidbüchel K, Wood WG, Scriba PC.

Acta Endocrinol (Copenh). 1984 Jul;106(3):350-6.

PMID:
6331036
15.
16.

Role of corticotrophin-releasing hormone in the impairment of counterregulatory responses to hypoglycemia.

Flanagan DE, Keshavarz T, Evans ML, Flanagan S, Fan X, Jacob RJ, Sherwin RS.

Diabetes. 2003 Mar;52(3):605-13.

18.

Recovery of hypothalamo-pituitary-adrenal function in asthmatics whose oral steroids have been stopped or reduced.

Harrison BD, Rees LH, Cayton RM, Nabarro JD.

Clin Endocrinol (Oxf). 1982 Aug;17(2):109-18.

PMID:
6290109
19.

Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone.

Brunton PJ, McKay AJ, Ochedalski T, Piastowska A, Rebas E, Lachowicz A, Russell JA.

J Neurosci. 2009 May 20;29(20):6449-60. doi: 10.1523/JNEUROSCI.0708-09.2009.

Supplemental Content

Support Center